Yonsei Med J.  2015 Mar;56(2):572-577. 10.3349/ymj.2015.56.2.572.

Increasing Carbapenem-Resistant Gram-Negative Bacilli and Decreasing Metallo-beta-Lactamase Producers over Eight Years from Korea

• Lee Y
• Kim CK
• Chung HS
• Yong D
• Jeong SH
• Lee K
• Chong Y

• KMID: 2070040
• DOI: http://doi.org/10.3349/ymj.2015.56.2.572

Abstract

The trends and types of carbapenemase-producing Gram-negative bacilli were analyzed from clinical specimens collected between 2005 and 2012 at a Korean teaching hospital. The proportions of carbapenem-resistant Acinetobacter spp. increased markedly to 66%. Metallo-beta-lactamase producers significantly decreased and the majority shifted from the bla(VIM-2) type to the bla(IMP-1) type.

Keyword

Gram-negative bacilli; carbapenem; metallo-beta-lactamase

MeSH Terms

Acinetobacter/classification/drug effects/*enzymology
Acinetobacter Infections/drug therapy
Anti-Bacterial Agents/*pharmacology
Bacterial Proteins
Carbapenems/*pharmacology
Drug Resistance, Microbial
Gram-Negative Bacteria/*drug effects/enzymology/isolation & purification
Humans
Incidence
Microbial Sensitivity Tests/trends
Population Surveillance
Pseudomonas/classification/drug effects/enzymology
Republic of Korea/epidemiology
beta-Lactamases/biosynthesis/*drug effects
Anti-Bacterial Agents
Bacterial Proteins
Carbapenems
beta-Lactamases

Reference

1. Yong D, Shin HB, Kim YK, Cho J, Lee WG, Ha GY, et al. Increase in the prevalence of carbapenem-resistant Acinetobacter isolates and ampicillin-resistant non-typhoidal Salmonella species in Korea: a KONSAR study conducted in 2011. Infect Chemother. 2014; 46:84–93.

2. Walsh TR. Clinically significant carbapenemases: an update. Curr Opin Infect Dis. 2008; 21:367–371.

3. Poirel L, Nordmann P. Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology. Clin Microbiol Infect. 2006; 12:826–836.

4. Walsh TR, Toleman MA, Poirel L, Nordmann P. Metallo-beta-lactamases: the quiet before the storm? Clin Microbiol Rev. 2005; 18:306–325.

5. Yong D, Choi YS, Roh KH, Kim CK, Park YH, Yum JH, et al. Increasing prevalence and diversity of metallo-beta-lactamases in Pseudomonas spp., Acinetobacter spp., and Enterobacteriaceae from Korea. Antimicrob Agents Chemother. 2006; 50:1884–1886.

6. Lim Y, Lee Y, Seo Y, Yum JH, Yong D, Lee K, et al. Loss of bla_VIM-2 and bla_IMP-1 during the storage of gram-negative bacilli, antimicrobial susceptibility of the gene-lost strain, and location of the gene in the cell. Ann Clin Microbiol. 2013; 16:120–125.

7. Clinical and Laboratory Standards Institute (CLSI). Performance standards for antimicrobial susceptibility testing: twentieth informational supplement. M100-S20-U. Wayne, PA: CLSI;2010.

8. Lee K, Lim YS, Yong D, Yum JH, Chong Y. Evaluation of the Hodge test and the imipenem-EDTA double-disk synergy test for differentiating metallo-beta-lactamase-producing isolates of Pseudomonas spp. and Acinetobacter spp. J Clin Microbiol. 2003; 41:4623–4629.

9. Lee K, Lee WG, Uh Y, Ha GY, Cho J, Chong Y, et al. VIM- and IMP-type metallo-beta-lactamase-producing Pseudomonas spp. and Acinetobacter spp. in Korean hospitals. Emerg Infect Dis. 2003; 9:868–871.

10. Lee K, Yum JH, Yong D, Lee HM, Kim HD, Docquier JD, et al. Novel acquired metallo-beta-lactamase gene, bla_SIM-1, in a class 1 integron from Acinetobacter baumannii clinical isolates from Korea. Antimicrob Agents Chemother. 2005; 49:4485–4491.

11. Yong D, Toleman MA, Giske CG, Cho HS, Sundman K, Lee K, et al. Characterization of a new metallo-beta-lactamase gene, bla_NDM-1, and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India. Antimicrob Agents Chemother. 2009; 53:5046–5054.

12. Smith Moland E, Hanson ND, Herrera VL, Black JA, Lockhart TJ, Hossain A, et al. Plasmid-mediated, carbapenem-hydrolysing beta-lactamase, KPC-2, in Klebsiella pneumoniae isolates. J Antimicrob Chemother. 2003; 51:711–714.

13. Rodríguez-Martínez JM, Poirel L, Nordmann P. Molecular epidemiology and mechanisms of carbapenem resistance in Pseudomonas aeruginosa. Antimicrob Agents Chemother. 2009; 53:4783–4788.

14. Quale J, Bratu S, Gupta J, Landman D. Interplay of efflux system, ampC, and oprD expression in carbapenem resistance of Pseudomonas aeruginosa clinical isolates. Antimicrob Agents Chemother. 2006; 50:1633–1641.

15. Juan C, Zamorano L, Mena A, Albertí S, Pérez JL, Oliver A. Metallo-beta-lactamase-producing Pseudomonas putida as a reservoir of multidrug resistance elements that can be transferred to successful Pseudomonas aeruginosa clones. J Antimicrob Chemother. 2010; 65:474–478.

16. Evans BA, Amyes SG. OXA β-lactamases. Clin Microbiol Rev. 2014; 27:241–263.

17. Kouda S, Ohara M, Onodera M, Fujiue Y, Sasaki M, Kohara T, et al. Increased prevalence and clonal dissemination of multidrug-resistant Pseudomonas aeruginosa with the blaIMP-1 gene cassette in Hiroshima. J Antimicrob Chemother. 2009; 64:46–51.

18. Lee JY, Ko KS. OprD mutations and inactivation, expression of efflux pumps and AmpC, and metallo-β-lactamases in carbapenem-resistant Pseudomonas aeruginosa isolates from South Korea. Int J Antimicrob Agents. 2012; 40:168–172.

19. Cavalcanti FL, Almeida AC, Vilela MA, Morais MM, Morais Junior MA. Changing the epidemiology of carbapenem-resistant Pseudomonas aeruginosa in a Brazilian teaching hospital: the replacement of São Paulo metallo-β-lactamase-producing isolates. Mem Inst Oswaldo Cruz. 2012; 107:420–423.

20. Suh B, Bae IK, Kim J, Jeong SH, Yong D, Lee K. Outbreak of meropenem-resistant Serratia marcescens comediated by chromosomal AmpC beta-lactamase overproduction and outer membrane protein loss. Antimicrob Agents Chemother. 2010; 54:5057–5061.

21. Shin SY, Bae IK, Kim J, Jeong SH, Yong D, Kim JM, et al. Resistance to carbapenems in sequence type 11 Klebsiella pneumoniae is related to DHA-1 and loss of OmpK35 and/or OmpK36. J Med Microbiol. 2012; 61(Pt 2):239–245.

22. Lee Y, Choi H, Yum JH, Kang G, Bae IK, Jeong SH, et al. Molecular mechanisms of carbapenem resistance in Enterobacter cloacae clinical isolates from Korea and clinical outcome. Ann Clin Lab Sci. 2012; 42:281–286.